Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

Neuropsychopharmacology

Volumn 24, Issue 3, 2001, Pages 240-252

  Liechti, Matthias E ^a   Geyer, Mark A ^b   Hell, Daniel ^a   Vollenweider, Franz X ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3,4 Methylenedioxy N methylamphetamine; Citalopram; Ecstasy; H aloperidol; Habituation; Human; Ketanserin; MDMA; Prepulse inhibition; Serotonin; Startle

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CITALOPRAM; HALOPERIDOL; KETANSERIN; RECEPTOR; SEROTONIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HABITUATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX;

ACOUSTIC STIMULATION; ADULT; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HALOPERIDOL; HUMANS; KETANSERIN; MALE; MODELS, PSYCHOLOGICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STARTLE REACTION;

EID: 0035130579     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00199-8     Document Type: Article

References (57)

1. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man
2. Effects of bromocriptine and haloperidol on prepulse inhibition: Comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man
3. Repeated testing of prepulse inhibition and habituation of the startle reflex: A study in healthy human controls
4. The pharmacokinetics of citalopram
5. A double-blind double-dummy study of citalopram comparing infusion versus oral administration
6. Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia
7. Gating and habituation of the startle reflex in schizophrenic patients
8. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population
9. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder
10. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats
11. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans
12. International study on altered states of consciousness (ISASC). Summary of the results
13. Psychopharmacology of prepulse inhibition in mice
14. Serotonin 1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin 1B receptor knockout mice
15. 5-HT1B receptor modulation of prepulse inhibition: Recent findings in wild-type and 5-HT1B knockout mice
16. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain
17. Pharmacokinetics of haloperidol
18. Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research
19. Habituation of the blink reflex in normals and schizophrenic patients
20. Behavioral pharmacology of ring-substituted amphetamine analogs
21. Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans
22. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons
23. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: Implications for serotonin-dopamine interactions
24. 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
25. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans
26. The pharmacology of citalopram
27. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
28. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats
29. MDMA induced dopamine release in vivo: Role of endogenous serotonin
30. Caveat emptor: Researcher beware
31. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
32. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
33. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of MDMA ("Ecstasy") in healthy volunteers
34. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in normal healthy humans
35. Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat
36. Dopaminergic stimulation disrupts sensorimotor gating in the rat
37. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by a-Ethyltryptamine
38. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness
39. 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol
40. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
41. 5-HT1A agonists block prepulse inhibition of the acoustic startle reflex
42. Test-retest reliability of prepulse inhibition of the acoustic startle response
43. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males
44. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window
45. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats
46. 8-OH-DPAT disruption of prepulse inhibition in rats: Reversal with (+)WAY 100,135 and localization of site of action
47. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum
48. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder (OCD)
49. Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders
50. Ampetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine
51. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's Disease
52. Psychological and cardiovascular effects and short-term sequelae of MDMA ("Ecstasy") in MDMA-naive healthy volunteers
53. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
54. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
55. Is a single dose MDMA harmless?